Invacare (IVCRQ) Stock Price
Invacare Price
Invacare (IVCRQ) Stock | ISIN US4612031017 | WKN 868973. Invacare operates in the Health sector.
Invacare stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Invacare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Invacare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Invacare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Invacare Price |
|---|
Invacare Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Invacare Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Invacare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Invacare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Invacare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Invacare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Invacare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Invacare stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Invacare Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Invacare business model & stock analysis
Invacare SWOT Analysis
Strengths
Invacare Corp possesses several strengths that contribute to its competitive advantage and market position. These include a strong brand presence, a diverse product portfolio catering to a wide range of healthcare needs, and a global distribution network. The company's strong research and development capabilities enable it to continually innovate and stay ahead in the market.
Weaknesses
Despite its strengths, Invacare Corp also faces certain weaknesses that need to be addressed. These include challenges related to product quality control, regulatory compliance, and potential vulnerability to economic downturns. The company may also have limited financial resources compared to some of its competitors, which could impact its ability to invest in expansion or new initiatives.
Opportunities
Invacare Corp has several opportunities to capitalize on in the market. The growing global demand for healthcare products, technological advancements, and an aging population are all factors that can drive the demand for Invacare's products. The company may also explore strategic partnerships or acquisitions to expand its product offerings or enter new geographic markets.
Threats
Invacare Corp operates in a highly competitive market, facing threats from both new entrants and existing competitors. Rapid technological changes and the potential for disruptive innovations pose risks to the company's market share. Additionally, changing regulations and reimbursement policies in the healthcare industry can impact the demand for Invacare's products. Economic uncertainties and fluctuations in raw material prices are also potential threats that could affect the company's profitability.
Invacare Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Invacare historical P/E ratio, EBIT multiple, and P/S ratio
Invacare annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Invacare shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Invacare Dividend History
22 years of dividend payments
Invacare dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Invacare shareholder structure
| % | Name |
|---|---|
9.79202% | |
8.21535% | |
4.6224% | |
4.16674% | |
3.81949% | |
3.55805% | |
3.08843% | |
2.64077% | |
1.87933% | |
1.79992% |
Invacare Executives and Management Board
Ms. Kathleen Leneghan
(58)Chief Financial Officer, Senior Vice President
Mr. Anthony LaPlaca
(63)Senior Vice President, General Counsel, Chief Administrative Officer, Secretary
Mr. Joost Beltman
(53)Senior Vice President, General Manager, North America
Ms. Angela Goodwin
(57)Senior Vice President, Chief Information Technology Officer
Mr. Clifford Nastas
(59)Lead Independent Director
Frequently asked questions about Invacare
Invacare Corp is a global leader in the manufacture and distribution of medical equipment, including wheelchairs, respiratory devices, and home care beds. Their business model revolves around developing and providing innovative products and services to enhance the quality of life for people with disabilities or chronic conditions. With a focus on customer-centric solutions, Invacare Corp strives to meet the diverse and evolving needs of healthcare professionals, distributors, and end-users worldwide. Through their extensive product portfolio and commitment to innovation, Invacare Corp continues to drive positive change within the industry, improving mobility, independence, and overall wellbeing for individuals with special needs.
Invacare stock
Invacare Peer Group
Invacare Ticker
Invacare FIGI
All fundamentals and in-depth analysis of Invacare
Our stock analysis for Invacare Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Invacare Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.